Found: 50
Select item for more details and to access through your institution.
Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing Pseudomonas aeruginosa.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1410834
- By:
- Publication type:
- Article
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S295, doi. 10.1093/cid/ciad565
- By:
- Publication type:
- Article
Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018–2021.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S4, doi. 10.1093/cid/ciad261
- By:
- Publication type:
- Article
Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S20, doi. 10.1093/cid/ciad151
- By:
- Publication type:
- Article
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 1, p. 1, doi. 10.1093/jacamr/dlac131
- By:
- Publication type:
- Article
Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 122, doi. 10.1093/jac/dkac363
- By:
- Publication type:
- Article
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1035609
- By:
- Publication type:
- Article
Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/ avibactam and ceftolozane/ tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1007162
- By:
- Publication type:
- Article
Acquisition of resistance to ceftazidime-avibactam during infection treatment in Pseudomonas aeruginosa through D179Y mutation in one of two bla<sub>KPC-2</sub> gene copies without losing carbapenem resistance.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 01, doi. 10.3389/fcimb.2022.981792
- By:
- Publication type:
- Article
Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17598-x
- By:
- Publication type:
- Article
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11081101
- By:
- Publication type:
- Article
Phenotypic and Genotypic Characterization of Macrolide, Lincosamide and Streptogramin B Resistance among Clinical Methicillin-Resistant S taphylococcus aureus Isolates in Chile.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11081000
- By:
- Publication type:
- Article
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I).
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofab616
- By:
- Publication type:
- Article
Isolation of Ciprofloxacin and Ceftazidime-Resistant Enterobacterales From Vegetables and River Water Is Strongly Associated With the Season and the Sample Type.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.604567
- By:
- Publication type:
- Article
Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A multispecies outbreak of carbapenemresistant bacteria harboring the bla<sub>KPC</sub> gene in a non-classical transposon element.
- Published in:
- BMC Microbiology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12866-021-02169-3
- By:
- Publication type:
- Article
Higher Prevalence of Extended-Spectrum Cephalosporin-Resistant Enterobacterales in Dogs Attended for Enteric Viruses in Brazil Before and After Treatment with Cephalosporins.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 2, p. 122, doi. 10.3390/antibiotics10020122
- By:
- Publication type:
- Article
Covid-19 in South America: clinical and epidemiological characteristics among 381 patients during the early phase of the pandemic in Santiago, Chile.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62371-7
- By:
- Publication type:
- Article
In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 2, p. 62, doi. 10.3390/antibiotics9020062
- By:
- Publication type:
- Article
1827. Genetic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Associated with the Development of Reduced Susceptibility to Vancomycin from Latin America.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S41, doi. 10.1093/ofid/ofz359.089
- By:
- Publication type:
- Article
612. Molecular Mechanisms Leading to Ceftolozane–Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S285, doi. 10.1093/ofid/ofz360.681
- By:
- Publication type:
- Article
622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S289, doi. 10.1093/ofid/ofz360.690
- By:
- Publication type:
- Article
1597. Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S582, doi. 10.1093/ofid/ofz360.1461
- By:
- Publication type:
- Article
2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S768, doi. 10.1093/ofid/ofz360.1926
- By:
- Publication type:
- Article
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz416
- By:
- Publication type:
- Article
Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”.
- Published in:
- Case Reports in Infectious Diseases, 2019, p. 1, doi. 10.1155/2019/8314349
- By:
- Publication type:
- Article
Ceftaroline Susceptibility by Four Different Methods Using EUCAST and CLSI Breakpoints in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA).
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 17
- By:
- Publication type:
- Article
Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA).
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 32
- By:
- Publication type:
- Article
In vitro Activity of Ceftolozane/Tazobactam (C/T) Against Enterobacteriaceae and Pseudomonas aeruginosa Circulating in Chile.
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 34
- By:
- Publication type:
- Article
Molecular Mechanisms Leading to Ceftolozane-Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries.
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 36
- By:
- Publication type:
- Article
Phylogenomic epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) Chilean-Cordobes clone in Latin America.
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 38
- By:
- Publication type:
- Article
The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS).
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 41
- By:
- Publication type:
- Article
In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.
- Published in:
- Case Reports in Infectious Diseases, 2018, p. 1, doi. 10.1155/2018/9095203
- By:
- Publication type:
- Article
A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33148-w
- By:
- Publication type:
- Article
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 738, doi. 10.1093/cid/cix417
- By:
- Publication type:
- Article
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 158, doi. 10.1093/cid/cix014
- By:
- Publication type:
- Article
La crisis mundial de resistencia antimicrobiana y perspectivas de su combate futuro.
- Published in:
- Contacto Científico Clínica Alemana, 2017, v. 7, n. 2, p. 54
- By:
- Publication type:
- Article
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S24, doi. 10.1093/cid/ciw827
- By:
- Publication type:
- Article
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia TreatedWith Daptomycin: Is it Time to Change the Breakpoint?
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1514, doi. 10.1093/cid/ciw173
- By:
- Publication type:
- Article
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Mechanisms of drug resistance: daptomycin resistance.
- Published in:
- Annals of the New York Academy of Sciences, 2015, v. 1354, n. 1, p. 32, doi. 10.1111/nyas.12948
- By:
- Publication type:
- Article
Telavancin: The Long and Winding Road From Discovery to Food and Drug Administration Approvals and Future Directions.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S38, doi. 10.1093/cid/civ522
- By:
- Publication type:
- Article
A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 8, p. 1317, doi. 10.1093/infdis/jiu602
- By:
- Publication type:
- Article
Failure of High-Dose Daptomycin for Bacteremia Caused by Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 9, p. 1277, doi. 10.1093/cid/ciu642
- By:
- Publication type:
- Article
Resistencia a antibióticos de última línea en cocos Gram positivos: la era posterior a la vancomicina.
- Published in:
- Biomédica: Revista del Instituto Nacional de Salud, 2014, v. 34, n. S1, p. 191, doi. 10.7705/biomedica.v34i0.2210
- By:
- Publication type:
- Article
Dissecting the Mechanisms of Linezolid Resistance in a Drosophila melanogaster Infection Model of Staphylococcus aureus.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 1, p. 83, doi. 10.1093/infdis/jit138
- By:
- Publication type:
- Article
Editorial Commentary: Enterococcus faecalis Infective Endocarditis: Is It Time to Abandon Aminoglycosides?
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 9, p. 1269, doi. 10.1093/cid/cit050
- By:
- Publication type:
- Article